Biochemical and Biophysical Research Communications
ReviewGenetic basis of rheumatoid arthritis: A current review
Section snippets
Genetic aspects of rheumatoid arthritis
Rheumatoid arthritis (RA) is one of the most common forms of autoimmune arthritis, affecting approximately 0.5–1.0% of the world’s population. The serum of most RA patients contains autoantibodies, such as rheumatoid factor (RF) or anti-citrullinated protein antibodies (ACPAs), the presence of which constitutes one of the new classification criteria for RA revised in 2010 [1]. Although RF is also present in other autoimmune diseases and immunological conditions, such as chronic infection and
HLA-DRB1 gene
Since the first evidence suggesting the involvement of human leukocyte antigens (HLAs) in RA was reported in 1969 [10], polymorphisms in the HLA region have been at the center of genetic studies of RA. That study demonstrated reduced lymphocyte responses in autologous mixed cultures of cells from RA patients, suggesting that polymorphisms in HLA genes (which encode the major histocompatibility complex [MHC] molecules that present antigens to T cells) are shared among patients [10].
Insights from GWASs
In a GWAS, ∼1 million single-nucleotide polymorphisms (SNPs) are simultaneously genotyped for affected patients (cases) and non-affected individuals (controls). The null hypothesis of a GWAS is that there is no association between a given SNP and disease susceptibility and is tested by comparing the allele frequency or genotype frequency between cases and controls. If the null hypothesis is rejected with a genome-wide significance level, which is usually set at α = 5 × 10−8, the genetic marker
RA risk genes and pathogenesis
As mentioned above, GWASs have identified more than 100 RA risk loci. Although the effect of each individual locus is moderate (e.g., the odds ratio for most individual alleles ranges between 1.1 and 1.3), detailed analyses of individual loci to identify disease-causing variants and to determine the effect of the identified variants on responsible genes (e.g., gain-of-function or loss-of-function) would enhance our understanding of the disease. Examples of RA risk genes and their role in the
Missing heritability
The GWAS approach has proven to be a powerful means of identifying risk loci that control complex traits under the common disease–common variant hypothesis, which assumes that common variants of modest effect are responsible for common diseases [73]. However, it is becoming apparent that common variants can explain only a small proportion of the heritability of these diseases. In RA, the 100 risk loci identified outside the HLA region explain only 5.5% and 4.7% of the total risk of developing
Clinical use of genetic data in RA
In the final section of this review, we discuss the use of genetic data in clinical practice as it pertains to treating RA. The use of genetic data represents a challenge in the post-GWAS era because RA is a very heterogeneous disease with an outcome that is difficult to predict. The heterogeneity of RA can be partially explained by genetic factors; that is, the specific combination of genetic factors in an individual can determine the outcome of the disease. In this context, GWAS data can be
Acknowledgments
This work was supported by grants from the Ministry of Education, Culture, Sports, Sciences and Technology and the Ministry of Health, Labor and Welfare of the Japanese government.
References (88)
- et al.
Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis
Am. J. Hum. Genet.
(2007) - et al.
Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity
Am. J. Hum. Genet.
(2014) - et al.
A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis
Am. J. Hum. Genet.
(2004) - et al.
The role of PTPN22 in autoimmunity: learning from mice
Autoimmun. Rev.
(2014) - et al.
Meta-analysis reveals an association of STAT4 polymorphisms with systemic autoimmune disorders and anti-dsDNA antibody
Hum. Immunol.
(2013) - et al.
Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene
Am. J. Hum. Genet.
(2010) - et al.
Rare, low-frequency, and common variants in the protein-coding sequence of biological candidate genes from GWASs contribute to risk of rheumatoid arthritis
Am. J. Hum. Genet.
(2013) - et al.
Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Arthritis Rheum.
(2010) - et al.
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies
J. Clin. Invest.
(1998) - et al.
Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age
Arthritis Rheum.
(2013)
Twin concordance rates for rheumatoid arthritis: results from a nationwide study
Br. J. Rheumatol.
Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins
Arthritis Rheum.
Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis
Arthritis Rheum.
The International HapMap Project
Nature
Environmental influences on risk for rheumatoid arthritis
Curr. Opin. Rheumatol.
Environmental exposures and rheumatoid arthritis risk
Curr. Rheumatol. Rep.
Altered reactivity in mixed lymphocyte culture of lymphocytes from patients with rheumatoid arthritis
Arthritis Rheum.
Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis
Arthritis Rheum.
Association of the B-cell alloantigen DRw4 with rheumatoid arthritis
N. Engl. J. Med.
HLA-DR genotype risks in seropositive rheumatoid arthritis
Am. J. Hum. Genet.
The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
Arthritis Rheum.
Association of the HLA-DRB1 epitope LA(67, 74) with rheumatoid arthritis and citrullinated vimentin binding
Arthritis Rheum.
Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis
Nat. Genet.
Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen
Arthritis Rheum.
Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis
Arthritis Rheum.
Association of rheumatoid factors and anti-filaggrin antibodies with severity of erosions in rheumatoid arthritis
Rheumatology (Oxford)
An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: effects of ∗09:01 allele on disease phenotypes
Rheumatology (Oxford)
Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1∗0401 MHC class II molecule
J. Immunol.
A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis
J. Exp. Med.
Immunity to citrullinated proteins in rheumatoid arthritis
Annu. Rev. Immunol.
Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis
Ann. Rheum. Dis.
A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination
Arthritis Rheum.
Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles
Ann. Rheum. Dis.
Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile
Ann. Rheum. Dis.
Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis
Nat. Genet.
Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis
Arthritis Rheum.
Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles
Arthritis Rheum.
ACPA-negative RA consists of two genetically distinct subsets based on RF positivity in Japanese
PLoS One
Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis
Nat. Genet.
Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls
Nature
Rheumatoid arthritis association at 6q23
Nat. Genet.
TRAF1-C5 as a risk locus for rheumatoid arthritis – a genomewide study
N. Engl. J. Med.
REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis
Nat. Genet.
A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility
Nat. Genet.
Cited by (44)
Influence of immunomodulatory drugs on the gut microbiota
2021, Translational ResearchCitation Excerpt :For years, studies found only minimal genetic substrate for diseases such as MS and RA.206,207 It was only when multicenter, multinational consortia standardized data collection techniques and pooled thousands of cases that a clear picture emerged,208,209 and now well over 230 genes have been linked to MS risk.210 As with all biomarkers, best practice would mandate that microbiota of interest should be first identified in a discovery cohort and subsequently verified using a separate validation cohort.
Evaluation of anti-inflammatory and anti-arthritic property of ethanolic extract of Clitoria ternatea
2021, Chinese Herbal MedicinesCitation Excerpt :Although the exact cause of RA is unknown, the interaction of genetic and environmental factors is believed to trigger an autoimmune response in the body. The condition is most likely triggered by a combination of factors including genetics (Kochi, Suzuki, & Yamamoto, 2014), age, injury, environmental triggers which includes infections (Fortunato, 1996), smoking and hormones. Common symptom of RA includes, joint pain and swelling, stiffness, fatigue, depression, anaemia, flu like symptoms, such as fever, sweating.
Effect of lentivirus-mediated overexpression or silencing of MnSOD on apoptosis of resveratrol-treated fibroblast-like synoviocytes in rheumatoid arthritis
2019, European Journal of PharmacologyCitation Excerpt :RA is a complicated and heterogeneous chronic disease with the characteristics of progressive joint destruction, deformity and disability (Bottini and Firestein, 2012; Phull et al., 2018). Although the pathogenesis of RA is unclear at present, it is associated with not only genetic but also environmental factors (Karlson and Deane, 2012; Kochi et al., 2014; Sparks and Costenbader, 2014). Many studies suggest that RA-FLSs are involved in the pathogenic process of RA.
Human Leukocyte Antigen–Disease Associations in Rheumatoid Arthritis
2017, Rheumatic Disease Clinics of North AmericaCitation Excerpt :As a result, NF-κB signaling is enhanced; in mice with ablation of Tnfaip3, there is spontaneous inflammatory polyarthritis.105 Additional information about GWAS-based RA association data is discussed elsewhere.100,106–108 Finally, it should be added that the contribution of the HLA locus to RA susceptibility is far higher than any of the known non-HLA loci, with the DRB1-associated risk alone being greater than the aggregate contribution of all known non-HLA risk loci.
Utilization of nanoparticle technology in rheumatoid arthritis treatment
2016, Biomedicine and PharmacotherapyCitation Excerpt :Thus inhibition of angiogenesis may stop the inflammation and represent a new approach to the treatment of RA. The genes encoding several proteins such as human leukocyte antigens which encodes the polymorphic β-chain of the DR molecule (HLA-DRβ1), protein tyrosine phosphatase non receptor 22 (PTPN22), Cytotoxic T lymphocyte antigen 4 (CTLA4), tumor necrosis factor-a-induced protein 3 (TNFAIP3), C-C chemokine receptor type 6 (CCR6) and signal transducer and activator of transcription 4 (STAT4) can be considered as risk factor for RA [2,18]. In addition to genetic factors, environmental factors such as bacterial and viral infections can also be associated with polyarthritis in patients who are genetically susceptible.
Association of XRCC1 and OGG1 DNA repair gene polymorphisms with rheumatoid arthritis in Egyptian patients
2016, GeneCitation Excerpt :The nature of progressive joint damage in RA varies considerably between individuals. Patients who would experience more rapid progression need more extensive therapy (Kochi et al. 2014). Regarding the pathobiology of RA, oxidative stress induced by reactive oxygen species (ROS) is an important mechanism that underlies destructive and proliferative synovitis (Tak et al. 2000; Hitchon and El-Gabalawy 2004).